vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and FTC Solar, Inc. (FTCI). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $32.9M, roughly 1.9× FTC Solar, Inc.). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -110.7%, a 39.8% gap on every dollar of revenue. On growth, FTC Solar, Inc. posted the faster year-over-year revenue change (148.9% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-8.4M). Over the past eight quarters, FTC Solar, Inc.'s revenue compounded faster (61.6% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
FTC Solar, Inc. is a leading global provider of advanced solar tracker systems, associated components, and supporting software for solar projects. It serves utility-scale, commercial, and industrial solar segments across key global markets, helping customers boost energy generation efficiency and lower overall project costs.
CTKB vs FTCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $32.9M |
| Net Profit | $-44.1M | $-36.4M |
| Gross Margin | 52.9% | 14.9% |
| Operating Margin | -9.0% | -17.2% |
| Net Margin | -70.9% | -110.7% |
| Revenue YoY | 8.1% | 148.9% |
| Net Profit YoY | -557.1% | -197.4% |
| EPS (diluted) | — | $-2.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $32.9M | ||
| Q3 25 | $52.3M | $26.0M | ||
| Q2 25 | $45.6M | $20.0M | ||
| Q1 25 | $41.5M | $20.8M | ||
| Q4 24 | $57.5M | $13.2M | ||
| Q3 24 | $51.5M | $10.1M | ||
| Q2 24 | $46.6M | $11.4M | ||
| Q1 24 | $44.9M | $12.6M |
| Q4 25 | $-44.1M | $-36.4M | ||
| Q3 25 | $-5.5M | $-23.9M | ||
| Q2 25 | $-5.6M | $-15.4M | ||
| Q1 25 | $-11.4M | $-3.8M | ||
| Q4 24 | $9.6M | $-12.2M | ||
| Q3 24 | $941.0K | $-15.4M | ||
| Q2 24 | $-10.4M | $-12.2M | ||
| Q1 24 | $-6.2M | $-8.8M |
| Q4 25 | 52.9% | 14.9% | ||
| Q3 25 | 52.7% | 6.1% | ||
| Q2 25 | 52.3% | -19.6% | ||
| Q1 25 | 48.6% | -16.6% | ||
| Q4 24 | 58.5% | -29.1% | ||
| Q3 24 | 56.3% | -42.5% | ||
| Q2 24 | 54.6% | -20.5% | ||
| Q1 24 | 51.3% | -16.7% |
| Q4 25 | -9.0% | -17.2% | ||
| Q3 25 | -17.6% | -29.6% | ||
| Q2 25 | -23.3% | -57.5% | ||
| Q1 25 | -36.1% | -50.8% | ||
| Q4 24 | 5.2% | -101.7% | ||
| Q3 24 | -8.2% | -147.8% | ||
| Q2 24 | -18.3% | -104.3% | ||
| Q1 24 | -23.9% | -99.3% |
| Q4 25 | -70.9% | -110.7% | ||
| Q3 25 | -10.5% | -92.0% | ||
| Q2 25 | -12.2% | -77.2% | ||
| Q1 25 | -27.5% | -18.4% | ||
| Q4 24 | 16.8% | -92.7% | ||
| Q3 24 | 1.8% | -151.5% | ||
| Q2 24 | -22.4% | -107.1% | ||
| Q1 24 | -13.8% | -69.7% |
| Q4 25 | — | $-2.31 | ||
| Q3 25 | — | $-1.61 | ||
| Q2 25 | — | $-1.18 | ||
| Q1 25 | — | $-0.58 | ||
| Q4 24 | — | $-0.95 | ||
| Q3 24 | — | $-1.21 | ||
| Q2 24 | — | $-0.97 | ||
| Q1 24 | — | $-0.70 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $21.1M |
| Total DebtLower is stronger | — | $9.9M |
| Stockholders' EquityBook value | $341.7M | $-43.0M |
| Total Assets | $461.5M | $111.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $21.1M | ||
| Q3 25 | $93.3M | $24.4M | ||
| Q2 25 | $75.5M | $3.5M | ||
| Q1 25 | $95.3M | $5.9M | ||
| Q4 24 | $98.7M | $11.2M | ||
| Q3 24 | $162.3M | $8.3M | ||
| Q2 24 | $177.9M | $10.8M | ||
| Q1 24 | $168.8M | $14.0M |
| Q4 25 | — | $9.9M | ||
| Q3 25 | — | $16.6M | ||
| Q2 25 | — | $10.9M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $-43.0M | ||
| Q3 25 | $378.6M | $-13.7M | ||
| Q2 25 | $377.6M | $9.0M | ||
| Q1 25 | $379.6M | $15.5M | ||
| Q4 24 | $395.7M | $19.0M | ||
| Q3 24 | $385.5M | $30.4M | ||
| Q2 24 | $389.1M | $44.2M | ||
| Q1 24 | $392.6M | $55.2M |
| Q4 25 | $461.5M | $111.8M | ||
| Q3 25 | $494.9M | $111.5M | ||
| Q2 25 | $493.3M | $83.0M | ||
| Q1 25 | $482.6M | $84.1M | ||
| Q4 24 | $499.5M | $89.9M | ||
| Q3 24 | $491.2M | $91.7M | ||
| Q2 24 | $483.7M | $100.3M | ||
| Q1 24 | $492.1M | $115.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.20× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-8.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $-8.4M |
| FCF MarginFCF / Revenue | -2.9% | -25.7% |
| Capex IntensityCapex / Revenue | 1.6% | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-34.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-8.0M | ||
| Q3 25 | $-3.9M | $-14.6M | ||
| Q2 25 | $108.0K | $-2.3M | ||
| Q1 25 | $-125.0K | $-8.5M | ||
| Q4 24 | $2.0M | $-16.7M | ||
| Q3 24 | $13.2M | $-2.4M | ||
| Q2 24 | $6.2M | $-3.8M | ||
| Q1 24 | $4.0M | $-11.9M |
| Q4 25 | $-1.8M | $-8.4M | ||
| Q3 25 | $-4.6M | $-15.1M | ||
| Q2 25 | $-1.5M | $-2.5M | ||
| Q1 25 | $-974.0K | $-8.6M | ||
| Q4 24 | $1.1M | $-17.0M | ||
| Q3 24 | $12.2M | $-2.6M | ||
| Q2 24 | $5.2M | $-4.5M | ||
| Q1 24 | $3.4M | $-12.3M |
| Q4 25 | -2.9% | -25.7% | ||
| Q3 25 | -8.7% | -57.9% | ||
| Q2 25 | -3.2% | -12.4% | ||
| Q1 25 | -2.3% | -41.2% | ||
| Q4 24 | 1.9% | -128.6% | ||
| Q3 24 | 23.7% | -25.6% | ||
| Q2 24 | 11.0% | -39.2% | ||
| Q1 24 | 7.6% | -97.6% |
| Q4 25 | 1.6% | 1.3% | ||
| Q3 25 | 1.3% | 1.7% | ||
| Q2 25 | 3.5% | 0.9% | ||
| Q1 25 | 2.0% | 0.4% | ||
| Q4 24 | 1.6% | 2.2% | ||
| Q3 24 | 2.0% | 2.2% | ||
| Q2 24 | 2.3% | 6.1% | ||
| Q1 24 | 1.3% | 3.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FTCI
| Products | $26.2M | 80% |
| Services | $6.7M | 20% |
